Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis
Eleni Efstathiou
Fil Manuguid
Peter Kirkpatrick

Showing results (31-40 of 476) with videos related to

Pageof 48
Sort By:
Future Oncology (London, England)|January 19, 2021
Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countriesGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
European Urology Oncology|August 15, 2019
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer PatientsEleni Efstathiou, Mark Titus, Sijin Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in boneEleni Efstathiou, Mark Titus, Dimitra Tsavachidou, et al.
European Urology|October 27, 2009
Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classificationEleni Efstathiou, Neil A Abrahams, Rita F Tibbs, et al.
Drugs & Aging|June 8, 2019
Systemic Treatment of Prostate Cancer in Elderly Patients: Current Role and Safety Considerations of Androgen-Targeting StrategiesMyrto Boukovala, Nicholas Spetsieris, Eleni Efstathiou
Nephro-Urology Monthly|April 12, 2013
Androgen deprivation therapy and cardiovascular riskPanagiotis Mourmouris, Eleni Efstathiou, Athanasios Papatsoris
Scientific Reports|October 18, 2016
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate CancerSankar N Maity, Mark A Titus, Revekka Gyftaki, et al.
Nature Reviews. Urology|September 7, 2010
Therapeutic targeting of the prostate cancer microenvironmentMaria Karlou, Vassiliki Tzelepi, Eleni Efstathiou
Expert Opinion on Pharmacotherapy|June 17, 2020
An evaluation of apalutamide for the treatment of prostate cancerMyrto Boukovala, Nicholas Spetsieris, Eleni Efstathiou
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Reply to J.B. Aragon-Ching and D. Dalela et alAna Aparicio, Christopher J Logothetis
Pageof 48

Showing results (31-40 of 476) with videos related to

Sort By:
Pageof 48
Future Oncology (London, England)|January 19, 2021
Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countriesGeorge Kafatos, Victoria Banks, Peter Burdon, et al.
European Urology Oncology|August 15, 2019
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer PatientsEleni Efstathiou, Mark Titus, Sijin Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in boneEleni Efstathiou, Mark Titus, Dimitra Tsavachidou, et al.
European Urology|October 27, 2009
Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classificationEleni Efstathiou, Neil A Abrahams, Rita F Tibbs, et al.
Drugs & Aging|June 8, 2019
Systemic Treatment of Prostate Cancer in Elderly Patients: Current Role and Safety Considerations of Androgen-Targeting StrategiesMyrto Boukovala, Nicholas Spetsieris, Eleni Efstathiou
Nephro-Urology Monthly|April 12, 2013
Androgen deprivation therapy and cardiovascular riskPanagiotis Mourmouris, Eleni Efstathiou, Athanasios Papatsoris
Scientific Reports|October 18, 2016
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate CancerSankar N Maity, Mark A Titus, Revekka Gyftaki, et al.
Nature Reviews. Urology|September 7, 2010
Therapeutic targeting of the prostate cancer microenvironmentMaria Karlou, Vassiliki Tzelepi, Eleni Efstathiou
Expert Opinion on Pharmacotherapy|June 17, 2020
An evaluation of apalutamide for the treatment of prostate cancerMyrto Boukovala, Nicholas Spetsieris, Eleni Efstathiou
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Reply to J.B. Aragon-Ching and D. Dalela et alAna Aparicio, Christopher J Logothetis
Pageof 48